Gastroenterology
Volume 137, Issue 6 , Pages 2074-2083 , December 2009

Enteropathogenic Escherichia coli Infection Inhibits Intestinal Serotonin Transporter Function and Expression

  • Ali Esmaili

      Affiliations

    • Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Saad F. Nazir

      Affiliations

    • Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Alip Borthakur

      Affiliations

    • Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Dan Yu

      Affiliations

    • Department of Pathology, University of Chicago, Chicago, Illinois
    • ,
  • Jerrold R. Turner

      Affiliations

    • Department of Pathology, University of Chicago, Chicago, Illinois
    • ,
  • Seema Saksena

      Affiliations

    • Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Amika Singla

      Affiliations

    • Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Gail A. Hecht

      Affiliations

    • Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Waddah A. Alrefai

      Affiliations

    • Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois
    • ,
  • Ravinder K. Gill

      Affiliations

    • Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois
    • Corresponding Author InformationReprint requests Address requests for reprints to: Ravinder K. Gill, PhD, research assistant professor, University of Illinois at Chicago, Jesse Brown V. A. Medical Center, Medical Research Service (600/151), 820 South Damen Ave, Chicago, Illinois 60612. fax: (312) 569-7458

Received 18 March 2009 ,Accepted 3 September 2009.

References 

  1. Tobe T, Fujiwara M, Tanaka C. Distribution of serotonin (5-hydroxytryptamine) in the human gastrointestinal tract. Am J Gastroenterol. 1966;46:34–37
  2. Gill RK, Saksena S, Tyagi S, et al. Serotonin inhibits Na+/H+ exchange activity via 5-HT4 receptors and activation of PKC α in human intestinal epithelial cells. Gastroenterology. 2005;128:962–974
  3. Chen JX, Pan H, Rothman TP, et al. Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception. Am J Physiol. 1998;275:G433–G448
  4. Takayanagi S, Hanai H, Kumagai J, et al. Serotonin uptake and its modulation in rat jejunal enterocyte preparation. J Pharmacol Exp Ther. 1995;272:1151–1159
  5. Gill RK, Pant N, Saksena S, et al. Function, expression, and characterization of the serotonin transporter in the native human intestine. Am J Physiol Gastrointest Liver Physiol. 2008;294:G254–G262
  6. Miwa J, Echizen H, Matsueda K, et al. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion. 2001;63:188–194
  7. Bellini M, Rappelli L, Blandizzi C, et al. Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Am J Gastroenterol. 2003;98:2705–2711
  8. Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126:1657–1664
  9. Wheatcroft J, Wakelin D, Smith A, et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil. 2005;17:863–870
  10. Hecht G. Microbes and microbial toxins: paradigms for microbial-mucosal interactions (VII. Enteropathogenic Escherichia coli: physiological alterations from an extracellular position). Am J Physiol Gastrointest Liver Physiol. 2001;281:G1–G7
  11. McNamara BP, Koutsouris A, O'Connell CB, et al. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest. 2001;107:621–629
  12. Borthakur A, Gill RK, Hodges K, et al. Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level. Am J Physiol Gastrointest Liver Physiol. 2006;290:G30–G35
  13. Gill RK, Borthakur A, Hodges K, et al. Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E coli. J Clin Invest. 2007;117:428–437
  14. Hecht G, Hodges K, Gill RK, et al. Differential regulation of Na+/H+ exchange isoform activities by enteropathogenic E coli in human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2004;287:G370–G378
  15. Hodges K, Gill R, Ramaswamy K, et al. Rapid activation of Na+/H+ exchange by EPEC is PKC mediated. Am J Physiol Gastrointest Liver Physiol. 2006;291:G959–G968
  16. Dean P, Maresca M, Schuller S, et al. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc Natl Acad Sci U S A. 2006;103:1876–1881
  17. Savkovic SD, Villanueva J, Turner JR, et al. Mouse model of enteropathogenic Escherichia coli infection. Infect Immun. 2005;73:1161–1170
  18. Martel F, Monteiro R, Lemos C. Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J Pharmacol Exp Ther. 2003;306:355–362
  19. Esmann M. ATPase and phosphatase activity of Na+,K+-ATPase: molar and specific activity, protein determination. Methods Enzymol. 1988;156:105–115
  20. Newaz MA, Ranganna K, Oyekan AO. Relationship between PPARα activation and NO on proximal tubular Na+ transport in the rat. BMC Pharmacol. 2004;4:1
  21. Borthakur A, Gill RK, Tyagi S, et al. The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. J Nutr. 2008;138:1355–1359
  22. Berteloot A, Bennetts RW, Ramaswamy K. Transport characteristics of papain-treated brush border membrane vesicles: noninvolvement of g-glutamyltransferase in leucine transport. Biochim Biophys Acta. 1980;601:592–604
  23. Schmitz JC, Preiser H, Maestracci D, et al. Purification of human intestinal brush border membrane. Biochem Biophys Acta. 1973;322:98–112
  24. Sharma R, Tesfay S, Tomson FL, et al. Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2006;290:G685–G694
  25. Frankel G, Phillips AD, Rosenshine I, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol. 1998;30:911–921
  26. Donnenberg MS, Kaper JB, Finlay BB. Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol. 1997;5:109–114
  27. Donnenberg MS, Zhang HZ, Stone KD. Biogenesis of the bundle-forming pilus of enteropathogenic Escherichia coli: reconstitution of fimbriae in recombinant E coli and role of DsbA in pilin stability—a review. Gene. 1997;192:33–38
  28. Gauthier A, Puente JL, Finlay BB. Secretin of the enteropathogenic Escherichia coli type III secretion system requires components of the type III apparatus for assembly and localization. Infect Immun. 2003;71:3310–3319
  29. Daniell SJ, Takahashi N, Wilson R, et al. The filamentous type III secretion translocon of enteropathogenic Escherichia coli. Cell Microbiol. 2001;3:865–871
  30. Sekiya K, Ohishi M, Ogino T, et al. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc Natl Acad Sci U S A. 2001;98:11638–11643
  31. McDaniel TK, Kaper JB. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E coli K-12. Mol Microbiol. 1997;23:399–407
  32. Elliott SJ, Krejany EO, Mellies JL, et al. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun. 2001;69:4027–4033
  33. Kenny B, Jepson M. Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol. 2000;2:579–590
  34. Tu X, Nisan I, Yona C, et al. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol. 2003;47:595–606
  35. Kanack KJ, Crawford JA, Tatsuno I, et al. SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun. 2005;73:4327–4337
  36. Jayanthi LD, Samuvel DJ, Blakely RD, et al. Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Mol Pharmacol. 2005;67:2077–2087
  37. Samuvel DJ, Jayanthi LD, Bhat NR, et al. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci. 2005;25:29–41
  38. Celli J, Olivier M, Finlay BB. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J. 2001;20:1245–1258
  39. Malladi V, Shankar B, Williams PH, et al. Enteropathogenic Escherichia coli outer membrane proteins induce changes in cadherin junctions of Caco-2 cells through activation of PKCα. Microbes Infect. 2004;6:38–50
  40. Kenny B, Finlay BB. Intimin-dependent binding of enteropathogenic Escherichia coli to host cells triggers novel signaling events, including tyrosine phosphorylation of phospholipase C-γ1. Infect Immun. 1997;65:2528–2536
  41. Coudrier E, Kerjaschki D, Louvard D. Cytoskeleton organization and submembranous interactions in intestinal and renal brush borders. Kidney Int. 1988;34:309–320
  42. Iceta R, Aramayona JJ, Mesonero JE, et al. Regulation of the human serotonin transporter mediated by long-term action of serotonin in Caco-2 cells. Acta Physiol (Oxf). 2008;193:57–65
  43. Goosney DL, Gruenheid S, Finlay BB. Gut feelings: enteropathogenic E coli (EPEC) interactions with the host. Annu Rev Cell Dev Biol. 2000;16:173–189
  44. Borthakur A, Hodges K, Gill R, et al. Enteropathogenic E coli (EPEC) infection inhibits butyrate uptake in Caco-2 cells. Gastroenterology. 2004;126:A-295
  45. Borenshtein D, Fry RC, Groff EB, et al. Diarrhea as a cause of mortality in a mouse model of infectious colitis. Genome Biol. 2008;9:R122
  46. Meier Y, Eloranta JJ, Darimont J, et al. Regional distribution of solute carrier mRNA expression along the human intestinal tract. Drug Metab Dispos. 2007;35:590–594
  47. Foley KF, Pantano C, Ciolino A, et al. IFN-γ and TNF-α decrease serotonin transporter function and expression in Caco2 cells. Am J Physiol Gastrointest Liver Physiol. 2007;292:G779–G784
  48. Iceta R, Mesonero JE, Alcalde AI. Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells. Life Sci. 2007;80:1517–1524
  49. Said HM, Ortiz A, Kumar CK, et al. Transport of thiamine in human intestine: mechanism and regulation in intestinal epithelial cell model Caco-2. Am J Physiol. 1999;277:C645–C651
  50. Said HM, Ortiz A, Ma TY. A carrier-mediated mechanism for pyridoxine uptake by human intestinal epithelial Caco-2 cells: regulation by a PKA-mediated pathway. Am J Physiol Cell Physiol. 2003;285:C1219–C1225
  51. Saksena S, Gill R, Tyagi S, et al. Involvement of 5-HT3/4 receptor subtypes in the serotonin induced inhibition of Cl(−)/OH(−) exchange activity in Caco-2 cells. J Biol Chem. 2005;280:11859–11868
  52. Turner JR, Black ED. NHE3-dependent cytoplasmic alkalinization is triggered by Na(+)-glucose cotransport in intestinal epithelia. Am J Physiol Cell Physiol. 2001;281:C1533–C1541
  53. Pinto M, Robine-leon S, Tappay M. Enterocyte-like differentiation and polarization of the human colon cell line Caco-2 in culture. Biol Cell. 1983;47:323–330
  54. Shifflett DE, Clayburgh DR, Koutsouris A, et al. Enteropathogenic E coli disrupts tight junction barrier function and structure in vivo. Lab Invest. 2005;85:1308–1324
  55. Saksena S, Gill RK, Tyagi S, et al. Involvement of c-Src and protein kinase C δ in the inhibition of Cl(−)/OH− exchange activity in Caco-2 cells by serotonin. J Biol Chem. 2005;280:11859–11868
  56. Hodges K, Alto NM, Ramaswamy K, et al. The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell Microbiol. 2008;10:1735–1745
  57. Kaniga K, Uralil J, Bliska JB, et al. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol Microbiol. 1996;21:633–641
  58. Black DS, Marie-Cardine A, Schraven B, et al. The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cell Microbiol. 2000;2:401–414
  59. Vaughan RA. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters. J Pharmacol Exp Ther. 2004;310:1–7

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the National Institute of Diabetes and Digestive and Kidney Diseases grants DK-074459 (to R.K.G.), P01 DK-067887 (to G.A.H., J.R.T.), DK-09930 (to W.A.A.), DK 061931, and DK068271 (to J.R.T.).

PII: S0016-5085(09)01562-5

doi: 10.1053/j.gastro.2009.09.002

Gastroenterology
Volume 137, Issue 6 , Pages 2074-2083 , December 2009

Article Tools

* Image Usage & Resolution